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854Objective: Recent trials comparing on-pump (CABG) with off-pump coronary artery bypass grafting (OPCAB)
have been criticized by those who believe that surgeon inexperience may explain the apparent worse
outcomes for OPCAB. However, the true effect of surgeon volume on outcomes after OPCAB remains
unknown. The purpose of this study was to examine the effect of surgeon volume on risk-adjusted mortality after
OPCAB.
Methods: From 2003 to 2007, 709,483 patients underwent coronary artery bypass grafting operations
(CABG ¼ 439,253; OPCAB ¼ 270,230) within the Nationwide Inpatient Sample database. Hierarchic gener-
alized linear regression modeling with spline functions for annual individual operating surgeon volume was
used to assess the relationship between annual surgeon volume and inpatient mortality, adjusted for comorbid
disease and other potential confounders.
Results: OPCAB was performed in 38.1% of coronary artery bypass grafting operations. The average age for
those undergoing OPCABwas 66.1 11.1 years, and female patients accounted for 29.3% of operations with 1-
vessel (20.4%), 2-vessel (36.6%), 3-vessel (20.5%), or 4 vessels or more (13.6%). Median surgeon volume for
OPCABwas 105 (56–156) operations per year. A highly significant nonlinear relationship between surgeon vol-
ume and risk-adjusted mortality was observed for OPCAB operations (P<.01). Specifically, an estimated 5%
decrease in the absolute probability of death occurred after OPCAB performed by the surgeons with the highest
volume, which is greater than the 3% estimated decrease for conventional CABG. Of note, the effect of surgeon
volume on mortality was significantly less than other risk factors, such as the presence of heart failure, renal
failure, type of bypass conduit, and gender.
Conclusions: A significant surgeon volume–outcome relationship exists for mortality after OPCAB with
a threshold of more than 50 operations per year. However, the contribution of surgeon volume to the probability
of death is incrementally small compared with other patient and operative characteristics. This demonstrates that
outcomes after OPCAB are more dependent on patient risk factors than on surgeon volume. (J Thorac Cardio-
vasc Surg 2012;143:854-63)Surgeon preference to perform coronary artery bypass
grafting (CABG) with or without the use of cardiopulmo-
nary bypass (CPB) is motivated by many factors. Propo-
nents of off-pump coronary artery bypass (OPCAB)
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The Journal of Thoracic and Cardiovascular Surgwith CPB. Certain patient populations may derive dispro-
portionate benefits from the performance of OPCAB over
conventional CABG, including high-risk patients undergo-
ing cardiac surgery, female patients, octogenarians, and pa-
tients with renal failure.1-3 Thus, OPCAB may become
more common with an increasing number of centers
performing minimally invasive and robotic OPCAB in the
not too distant future. Although several clinical trials and
institutional reports have attempted to definitively
compare the safety and efficacy of both approaches,4-8
reported outcomes comparing OPCAB with CABG
remain mixed. In an effort to explain the disparate
differences in outcomes, some have suggested that
surgeon experience plays a role and emphasized the
importance of surgeon volume in establishing favorable
outcomes for OPCAB.9-11
Volume–outcome relationships within surgical practice
are well known. Studies investigating volume at the individ-
ual surgeon or hospital level are attractive to physicians and
administrators because they allow for an intuitive measure
of ‘‘expertise’’ and a proxy of enhanced safety and quality.ery c April 2012
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
ICD-9-
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¼ International Classification of
Diseases-Ninth Revision, Clinical
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DRelationships between surgeon volume and risk-adjusted
outcomes for cardiovascular procedures have been de-
scribed. In one large series, using Medicare claims data,
Birkmeyer and colleagues12 demonstrated the association
between annual surgeon volume and operative mortality
among several different surgical populations, including
those undergoing CABG and aortic valve replacements.
Furthermore, other studies have corroborated a significant
surgeon–volume relationship for on-pump CABG in the
past.13-15 However, comprehensive examinations of the
effect of surgeon volume on OPCAB outcomes remain
underreported.
The purpose of this study was to assess the relationship
between annual surgeon operative volume for the perfor-
mance of OPCAB and the probability of in-hospital
mortality after comprehensive adjustments for potential
confounding by differences in patient- and operation-
related characteristics. Accordingly, a multi-state patient
population undergoing surgical myocardial revasculariza-
tion was analyzed to test whether risk-adjusted mortality af-
ter isolated bypass grafting operations is significantly
associated with individual surgeon operative volume.MATERIALS AND METHODS
Data Source
Patient discharge records reported for in-hospital admissions from 2003
to 2007 included in the Nationwide Inpatient Sample (NIS) databases were
evaluated. The NIS represents a 20% stratified random sample of all hos-
pital discharges in the United States, and collection, validation, and main-
tenance of the datasets are performed by the Agency for Healthcare
Research and Quality.16 The NIS datasets represent the largest publicly
available inpatient care databases within the United States. Each year the
NIS captures patient discharges reported from approximately 1000 Amer-
ican Hospital Association hospitals. The NIS data use national hospital sur-
vey strata to weight each of the participating hospitals. Sampling strata
include 5 hospital characteristics: geographic region, urban or rural loca-
tion, ownership/control, teaching status, and hospital bed size. Weights
are provided for each discharge record, allowing nationally representative
study populations to be produced.
This study was exempt from formal review by the University of Vir-
ginia Institutional Review Board because it failed to meet the regula-
tory definition of human subjects research because patient identifiers
were absent and the data were collected for purposes other than
research.The Journal of Thoracic and CaPatients
Analysis of the effect of surgeon volume on mortality included 11 states
that specifically reported unique physician identifiers for the study time pe-
riod: Florida, Iowa, Kentucky, Maryland, New Hampshire, Nevada, New
York, Pennsylvania, Texas, Virginia, and West Virginia. States were ex-
cluded from analysis where principle surgeons were not identified or re-
ported surgeon identifiers may have represented surgeon groups or failed
to reliably track individual surgeons throughout multiple hospitals. The
study included discharge records in NIS datasets from 2003 to 2007 with
selected International Classification of Diseases, 9th Revision, Clinical
Modification (ICD-9-CM) procedure and diagnostic codes. Discharge re-
cords for patients with CABG procedures were identified using the follow-
ing ICD-9-CM procedure codes: 30.10, 36.11, 36.12, 36.13, 36.14, 36.15,
or 36.16. The concomitant use of CPB support was identified by records
that also included the following ICD-9-CM procedure codes for bypass
support: 39.61 or 39.66. Discharge records for patients with concomitant
cardiac valve procedures (ICD-9-CM codes 35.20, 35.21, 35.22, 35.23,
35.24, 35.25, 35.26, 35.27, 35.28, 35.11, 35.12, 35.13, 35.14) or other car-
diotomy (ICD-9-CM code 37.11) for purposes other than CPB were ex-
cluded. Patients were stratified by the use of CPB into OPCAB and
CABG with CPB support cohorts for descriptive purposes. The presence
of patient comorbid disease was assessed using Agency for Healthcare Re-
search and Quality comorbid disease categories developed by Elixhauser
and colleagues.17Hospitals
Hospital-level details were obtained through data available within the
NIS database. Hospitals were defined as teaching hospitals if they were
identified as having an AmericanMedical Association–approved residency
program, membership in the Council of Teaching Hospitals, or a 25% or
greater ratio of full-time equivalent interns and residents to patient beds.
Hospital bed size categories (small, medium, large) are defined in the
NIS on the basis of the proportion of short-term, acute beds available at
a given hospital. Surgeon and hospital operative volume were determined
by calculating the annual total number of isolated CABG operations per-
formed in each year of data. Hospital volumewas categorized into quartiles
for descriptive purposes: low (<25th percentile), medium (26–49th percen-
tile), high (50–74th percentile), and very high (>75th percentile).Outcomes Measured
The primary outcome of interest in this study was the probability of
in-hospital death. Secondary outcomes of interest included observed differ-
ences in patient comorbid disease, CABG-related details, hospital charac-
teristics, and overall mortality rates and hospital lengths of stay for study
groups. In-hospital death and hospital length of stay were identified from
individual discharge records.Statistical Analysis
Descriptive statistics. Descriptive statistics for continuous vari-
ables are reported as means standard deviation or as medians (interquar-
tile range) for skewed data. Differences in means were assessed using
single factor analysis of variance or the Wilcoxon rank-sum test. Descrip-
tive statistics for categoric variables are reported as percentages. Differ-
ences in proportions were compared using Pearson’s chi-square and
Fisher exact tests.
Multiple regression analysis. Hierarchic generalized multiple
linear regression models were developed to assess the relationship between
surgeon volume and risk-adjusted probability of in-hospital death. Separate
models were developed for cohorts of patients undergoing OPCAB or
CABG in each calendar year. The relationship between surgeon volume
and the probability of in-hospital death was represented as a nonlinear
polynomial function using restricted cubic spline transformations of therdiovascular Surgery c Volume 143, Number 4 855
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Dvolume measure. A common practice in the analysis of continuous data is
to distribute exposure into a series of percentile categories (eg, terciles,
quartiles). Conversion of continuous data into categoric data, however,
results in a loss of power to detect differences within and between cate-
gories. Spline functions use all data points to estimate the shape of an as-
sociation between an exposure (surgeon volume) and an outcome
(mortality).18 The use of splines provides a more robust method to deter-
mine whether nonlinearity exists between a continuous variable and a de-
pendent outcome.19-21
For each statistical model, preoperative variables considered potential
confounders for the effect of surgeon volume on mortality were selected
a priori and entered as model covariates. The following covariates were in-
cluded as potential confounders: number of grafts, single internal thoracic
artery (ITA), double ITA, elective status, gender, and 30 categories of co-
morbid disease measured using the Elixhauser method. All covariates con-
tributing cases to each estimated outcome, including nonsignificant
variables, were retained in the final models. Hierarchic generalized linear
regression models were used to provide appropriate adjustments for the
hospital-specific variance components estimated from the weighted study
population. Test statistics (F tests) obtained for each model covariate
were used to determine the relative predictive strength of each covariate
and to assess the statistical significance of the adjusted effect of the covar-
iate on the risk of in-hospital death. The maximum possible change in mor-
tality risk associated with changes in surgeon volume was measured using
the full mortality risk-adjustment model. The adjusted probability of mor-
tality was calculated for each patient using the full hierarchic generalized
linear model, for each year of available data, for OPCAB and CABG cases.
The minimum and maximum estimated probability of death associated
with the level of surgeon volume, controlling for all other factors, were
then assessed for the average patient. The absolute difference between
the minimum and maximum predicted risk of death represents the maxi-
mum possible change in patient mortality risk associated with changing
the level of surgeon volume from the lowest to highest level of volume
for the average patient. All statistical analyses were performed using
SAS version 9.2 (SAS Institute, Inc, Cary, NC).RESULTS
Patient, Hospital, and Operative Characteristics
Descriptive statistics for all patient, hospital, and opera-
tive characteristics are detailed in Table 1. Aweighted total
of 270,230 patients underwent OPCAB operations, whereas
439,253 patients underwent CABG procedures. The distri-
bution of isolated operations by operative year were
161,505 (22.8%) for 2003, 144,547 (20.4%) for 2004,
126,107 (17.8%) for 2005, 153,987 (21.7%) for 2006,
and 123,336 (17.4%) for 2007, and were consistently lower
than the performance of CABG (P<.001). The average pa-
tient age for both patient cohorts was 66 years. Female pa-
tients represented 29.3% of cases. The distribution of
annual surgeon volume displayed a prominent rightward
skew for both OPCAB and CABG. Thus, the number of sur-
geons performing operations at the high end of the surgeon
volume distribution was comparatively small (Figure 1).
Annual median surgeon volume was 105 for OPCAB and
110 for CABG procedures. Patients undergoing CABG
had significantly higher odds of undergoing elective opera-
tions (odds ratio, 1.44; confidence interval, 1.42–1.50). Pa-
tients with multivessel revascularization more commonly
underwent CABG procedures compared with OPCAB.856 The Journal of Thoracic and Cardiovascular SurgFew differences existed in the percentage of patients with
comorbid disease in the OPCAB and CABG groups. Com-
mon major comorbid diseases included chronic pulmo-
nary disease (22.6%), diabetes (28.7%), hypertension
(67.2%), and renal failure (7.5%). The majority of proce-
dures were performed in urban settings and at high-
volume hospitals.
Effect of Surgeon Volume on Risk-Adjusted
Mortality
A statistically significant relationship between surgeon
volume and in-hospital mortality for OPCAB cases was ob-
served for 3 of the 5 years (2004, 2006, 2007). Significant
relationships between surgeon volume and in-hospital mor-
tality for CABG cases were observed for 4 of 5 years (2003,
2004, 2006, 2007). Table 2 details the results of the multiple
regression models for the years 2004, 2006, and 2007
among OPCAB cases. In each model, a highly significant
nonlinear relationship between surgeon volume and risk-
adjusted mortality was observed for OPCAB operations
(2004: P ¼ .01, 2006: P ¼ .0004, 2007: P ¼ .005) after ad-
justment for a total of 38 different patient and operative
characteristics.
Comparison of the test statistic values obtained for each
covariate demonstrates that surgeon volume contributed
less to the predictive performance of the model than other
patient- and operation-related factors. For example, in the
2004 data, the test statistic for surgeon volume (F ¼ 11)
was relatively small compared with that of other highly sta-
tistically significant covariates, including renal failure
(F ¼ 210, P<.0001), hypertension (F ¼ 180, P<.0001),
female gender (F ¼ 102, P < .0001), use of single
(F ¼ 156, P<.0001) or double (F ¼ 32, P<.0001) ITAs,
or performance of elective operations (F ¼ 31,
P<.0001). Similar results were obtained for the effect of
surgeon volume on CABG operations: 2003 (F ¼ 16,
P ¼ .001), 2004 (F ¼ 22, P ¼ .0001), 2005 (F ¼ 7,
P ¼ .06), 2006 (F ¼ 19, P< .0001), and 2007 (F ¼ 13,
P ¼ .002).
Figure 2 displays the spline functions for the unadjusted
relationship between mortality risk and surgeon procedure
volume, for the OPCAB and CABG groups, for years
with statistically significant surgeon volume–outcome rela-
tionships (2004, 2006, and 2007). The functions illustrate
the nonlinear shape of the relations and pattern of decreased
risk of death. On the basis of these relationships, a threshold
for the greatest change in unadjusted mortality risk ap-
peared to occur after more than 50 OPCAB operations per
year, and the lowest probability of death was associated
with surgeon volumes of 150 OPCAB operations or more
per year. Of note, the confidence intervals dramatically wid-
ened for surgeon volumes greater than 150 to 200 opera-
tions per year, reflecting the small number surgeons with
such operative volumes. For CABG operations, similarery c April 2012
TABLE 1. Descriptive statistics for patients undergoing off-pump or
on-pump coronary artery bypass grafting
Variable OPCAB CABG OR (95% CI)
Unweighted frequency 56,215 91,233
Weighted frequency 270,230 439,253
Age (y)* 66.1  11.1 66.1  10.7
Female 30.3% 28.2% 0.90 (0.89–0.91)
Elective operation 41.7% 50.6% 1.44 (1.42–1.50)
Surgeon operative
volumey
105 (56–156) 111 (66–155)
Bypass grafts
1 vessel 19.1% 15.6% 0.78 (0.77–0.79)
2 vessel 34.2% 34.6% 1.02 (1.01–1.03)
3 vessel 27.5% 31.5% 1.21 (1.20–1.22)
>4 vessel 12.7% 15.2% 1.23 (1.21–1.25)
Single ITA 80.3% 79.5% 0.96 (0.94–0.97)
Double ITA 3.5% 3.0% 0.85 (0.83–0.87)
Gastroepiploic 0.1% <0.1% 0.60 (0.49–0.72)
No. of surgeons
2003 1937 2207
2004 1644 1737
2005 1771 1545
2006 1585 1496
2007 1516 1526
No. of hospitals
2003 91 91
2004 84 83
2005 72 72
2006 86 83
2007 78 77
Operative yearz
2003 31.7% 68.3%
2004 33.0% 67.0%
2005 45.7% 54.3%
2006 41.3% 58.7%
2007 40.6% 59.4%
Elixhauser comorbid
categories
Aids 0.1% 0.1% 0.65 (0.45–0.78)
Alcohol abuse 2.4% 2.0% 0.82 (0.80–0.85)
Deficiency anemia 14.8% 12.4% 0.82 (0.81–0.83)
RA and CVD 1.3% 1.4% 1.10 (1.05–1.14)
Chronic anemia 1.4% 1.1% 0.82 (0.79. 0.86)
Congestive heart failure 1.9% 0.7% 0.36 (0.34–0.38)
Chronic pulmonary
disease
24.2% 21.7% 0.87 (0.86–0.88)
Coagulopathy 10.1% 9.3% 0.91 (0.89–0.92)
Depression 3.8% 3.5% 0.93 (0.90–0.95)
Diabetes
(uncomplicated)
27.8% 29.3% 1.08 (1.06–1.09)
Diabetes (complicated) 5.3% 5.2% 0.97 (0.95–0.99)
Drug abuse 0.8% 0.6% 0.74 (0.69–0.78)
Hypertension 65.7% 68.1% 1.12 (1.10–1.13)
Hypothyroidism 6.6% 6.9% 1.04 (1.02–1.06)
Liver disease 0.8% 0.6% 0.77 (0.73–0.82)
Lymphoma 0.4% 0.3% 0.87 (0.80–0.94)
(Continued)
TABLE 1. Continued
Variable OPCAB CABG OR (95% CI)
Fluid and electrolyte
disorder
19.4% 15.5% 0.77 (0.76–0.78)
Metastatic cancer 0.2% 0.1% 0.73 (0.64–0.82)
Neurologic disorder 2.4% 2.1% 0.89 (0.86–0.92)
Obesity 10.6% 10.7% 1.00 (0.99–1.02)
Paralysis 1.0% 0.9% 0.90 (0.86–0.95)
Peripheral vascular
disease
12.9% 11.8% 0.90 (0.89–0.92)
Psychoses 1.0% 1.0% 0.96 (0.92–1.01)
Pulmonary circulatory
disease
0.1% <0.1% 0.31 (0.26–0.37)
Renal failure 8.7% 6.7% 0.75 (0.74–0.77)
Tumor (no metastases) 1.0% 1.0% 0.98 (0.93–1.03)
Peptic ulcer disease 0.1% <0.1% 0.77 (0.62–0.95)
Valve disease 1.0% 0.4% 0.34 (0.32–0.37)
Weight loss 1.7% 1.0% 0.58 (0.56–0.61)
Hospital location (urban) 96.2% 96.4% 1.06 (1.03–1.08)
Thoracic surgery teaching
hospital
8.3% 7.8% 0.94 (0.92–0.96)
Hospital region
Northeast 26.0% 26.9%
Midwest 11.1% 14.3%
South 51.3% 51.8%
West 11.6% 7.0%
Hospital operative volume
Low (<25th percentile) 3.8% 2.9%
Medium (26th–50th
percentile)
11.0% 10.0%
High (51st–75th
percentile)
21.5% 20.2%
Very high (>75th
percentile)
63.7% 66.8%
OR, Odds ratio; CI, confidence interval;CVD, collagen vascular disease; RA, rheuma-
toid arthritis. *Means  SD. yMedian (25th–75th quartiles). zReported results repre-
sent% of OPCAB versus CABG within each operative years. P<.001 for trend in
differences over study period.
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Dvolume–outcome relationships were revealed and appeared
more dramatic for low to medium surgeon volumes.
The magnitude of the change in risk-adjusted mortality
associated with surgeon volume, adjusted for the effects of
age, comorbid disease, and other confounders, was calcu-
lated using the full model equations for patients in the
OPCAB and CABG study populations (Table 3). The larg-
est possible change in the probability of death associated
with a change in surgeon volume ranged between 1.3%
and 5.4% for patients in the OPCAB study population
and between 1.6% and 3.4% for patients in the CABG
study population, depending on year. For example, the
minimum estimated probability of death associated with
the level of surgeon volume was 1.1% and the highest
was 6.5% among average patients in the OPCAB study
population for the 2003 calendar year, adjusted for all
other patient characteristics. Thus, moving an average pa-
tient from the lowest to the highest (or from highest tordiovascular Surgery c Volume 143, Number 4 857
FIGURE 1. Histograms representing the distribution of annual surgeon volume for the performance of both OPCAB and conventional CABG. CABG,
Coronary artery bypass grafting.
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Dlowest) possible level of surgery volume would yield
a 5.4% absolute difference in the probability of death
among average patients in the OPCAB study population
for the 2003 calendar year.
DISCUSSION
This study provides a population-based perspective on
the effect of surgeon volume on risk-adjusted mortality after
OPCAB operations compared with conventional on-pump
CABG. Examination of outcomes in a broadly generaliz-
able, multi-state patient population demonstrates that indi-
vidual surgeon volume has a statistically significant
nonlinear relationship with risk-adjusted mortality after ac-
counting for the potential confounding effects of 38 differ-
ent patient- and operation-related factors. The largest
possible change in the adjusted probability of death associ-
ated with a change in surgeon volume for OPCAB proce-
dures appears to range from 1% to 5%. Of note,
however, the relative strength of this association is small
compared with the effects estimated for many other well-
established cardiac surgical risk factors. Thus, in light of
continued debate regarding factors influencing outcomes
for CABG with and without the use of CPB, these data pro-
vide important insight into the relative impact of surgeon
volume compared with other patient factors on OPCAB
morality.
Accumulated data have reported varying results in com-
parisons of OPCAB with on-pump CABG, which has858 The Journal of Thoracic and Cardiovascular Surgresulted in an ensuing debate regarding the comparative ef-
fectiveness of one technique over the other. Proponents of
OPCAB cite the reduction in morbidity that may be related
to the avoidance of aortic cannulation or the effects of CPB,
whereas those who prefer CABGwith CPB often submit the
reduced completeness of revascularization and graft pa-
tency with OPCAB, as well as equivalent short- and long-
term morbidity and mortality between the 2 techniques. A
number of previous prospective randomized clinical trials
have provided significant data to support both sides of the
debate. In the Octopus trial, OPCAB was associated with
shorter hospital lengths of stay and reduced mechanical
ventilator requirements among a cohort of 281 patients,
whereas perioperative mortality rates were similar.8 These
results were further corroborated by Puskas and col-
leagues5,6 in 2 separate trials demonstrating equivalent
operative and 1-year outcomes, reduced resource use, lower
costs, and similar completeness of revascularization and
graft patency with OPCAB. In 2 additional trials, Angelini
and colleagues4 reported similar long-term outcomes de-
spite the use of CPB among experienced surgeons. Alterna-
tively, the recently published ROOBY trial demonstrated
worse 1-year composite outcomes, completeness of revas-
cularization, and graft patency for OPCAB, despite similar
30-day outcomes.7 Competing results between the 2 tech-
niques also exists within several large observational studies
and meta-analyses22,23; however, these series are subject to
inherent surgeon and institutional biases. Thus, these resultsery c April 2012
TABLE 2. Hierarchic logistic regression model results for off-pump coronary artery bypass in-hospital mortality
Covariate
2004 2006 2007
F P OR
95% CI
F P OR
95% CI
F P OR
95% CI
Lower Upper Lower Upper Lower Upper
Surgeon volume (spline)* 11 .01 NA 19 .0004 NA 13 .0046 NA
Gender (female) 102 <.0001 1.94 1.71 2.20 22 <.0001 1.30 1.16 1.45 52 <.0001 1.52 1.36 1.71
Bypass grafts
1 vessel 6 .01 0.68 0.51 0.92 1 .2999 0.88 0.68 1.13 3 .0843 0.81 0.64 1.03
2 vessel 1 .24 0.85 0.64 1.12 01 .4793 0.92 0.72 1.17 5 .0215 0.76 0.61 0.96
3 vessel 1 .32 0.87 0.66 1.15 7 .0088 0.72 0.56 0.92 10 .0014 0.67 0.53 0.86
>4 vessel 1 .30 0.84 0.62 1.16 1 .3486 0.88 0.67 1.15 20 <.0001 0.53 0.40 0.70
Single ITA 156 <.0001 0.42 0.36 0.48 317 <.0001 0.34 0.31 0.39 387 <.0001 0.29 0.25 0.33
Double ITA 32 <.0001 0.22 0.13 0.37 46 <.0001 0.19 0.12 0.31 96 <.0001 0.14 0.09 0.20
Comorbid disease
Elective operation 31 <.0001 0.66 0.57 0.76 29 <.0001 0.72 0.64 0.82 28 <.0001 0.72 0.63 0.81
AIDS 0.3 .6169 0.06 <0.001 >999.999 1 .2835 0.04 <0.001 15.71 1 .3966 0.02 <0.001 255.45
Alcohol abuse 0.1 .7466 0.94 0.62 1.41 3 .0651 0.71 0.50 1.02 3 .0847 0.70 0.46 1.05
Deficiency anemia 25 <.0001 0.52 0.40 0.67 75 <.0001 0.44 0.37 0.53 39 <.0001 0.60 0.51 0.70
RA and CVD 1 .3666 1.27 0.76 2.13 0.4 .5525 1.13 0.75 1.72 0.1 .7986 1.06 0.68 1.64
Chronic anemia 2 .1865 0.67 0.37 1.21 7 .0094 0.60 0.41 0.88 7 .0077 0.56 0.37 0.86
Congestive heart failure 15 <.0001 2.02 1.42 2.87 199 <.0001 4.32 3.52 5.29 88 <.0001 3.17 2.49 4.04
Chronic pulmonary
disease
9 .0034 0.80 0.69 0.93 1 .3875 1.05 0.94 1.18 1 .2675 1.07 0.95 1.21
Coagulopathy 47 <.0001 1.84 1.55 2.19 181 <.0001 2.30 2.04 2.60 137 <.0001 2.17 1.91 2.47
Depression 11 .0008 0.39 0.22 0.67 20 <.0001 0.40 0.27 0.59 34 <.0001 0.27 0.17 0.42
Diabetes
(uncomplicated)
40. <.0001 0.57 0.47 0.67 17 <.0001 0.76 0.67 0.87 60 <.0001 0.57 0.49 0.65
Diabetes (complicated) 26 <.0001 0.44 0.32 0.60 15 .0001 0.61 0.48 0.79 6 .0135 0.75 0.60 0.94
Drug abuse 34 .0613 0.05 0.00 1.15 8 .0041 0.26 0.11 0.65 7 .0092 0.04 0.00 0.45
Hypertension 180 <.0001 0.40 0.34 0.45 150 <.0001 0.51 0.45 0.56 166 <.0001 0.47 0.42 0.53
Hypothyroidism 32 <.0001 0.23 0.14 0.38 0.4 .5139 1.07 0.87 1.32 0.3 .5698 0.94 0.76 1.16
Liver disease 9 .0032 2.06 1.27 3.33 44 <.0001 3.32 2.33 4.74 4 .0517 0.52 0.27 1.01
Lymphoma 1 .264 1.59 0.71 3.57 10 .0015 2.30 1.38 3.84 1 .4322 0.79 0.43 1.44
Fluid and electrolyte
disorder
124 <.0001 2.20 1.91 2.53 84 <.0001 1.71 1.53 1.92 171 <.0001 2.16 1.92 2.42
Metastatic cancer 2 .1707 0.03 <0.001 4.28 41 <.0001 6.24 3.58 10.89 51 <.0001 7.77 4.42 13.65
Neurologic Disorder 33 <.0001 2.41 1.78 3.26 0.02 .8888 1.02 0.76 1.37 01 .7796 1.04 0.78 1.39
Obesity 23 <.0001 0.38 0.26 0.57 2 .1212 0.86 0.71 1.04 26 <.0001 0.54 0.43 0.69
Paralysis 25 <.0001 3.17 2.02 4.99 25 <.0001 2.72 1.83 4.04 56 <.0001 3.50 2.52 4.85
Peripheral vascular
disease
17 <.0001 1.46 1.22 1.76 0.3 .5893 1.04 0.90 1.21 8 .0053 1.22 1.06 1.41
Psychoses 1 .2316 0.59 0.24 1.41 10 .0018 0.21 0.08 0.57 2 .1352 0.64 0.35 1.15
Pulmonary circulatory
disease
0.2 .6807 0.02 <0.001 >999.999 8 .0064 0.36 0.17 0.75 1 .4221 1.30 0.68 2.49
Renal failure 210 <.0001 4.19 3.45 5.08 143 <.0001 2.23 1.96 2.55 116 <.0001 2.09 1.83 2.39
Tumor (no metastases) 34 .0479 0.05 0.00 0.97 1 .3857 1.23 0.77 1.98 4 .051 0.57 0.32 1.00
Peptic ulcer disease 0.4 .522 0.09 <0.001 132.54 0.1 .7253 0.07 <0.001 >999.999
Valve disease 3 .0736 1.52 0.96 2.40 0.8 .3793 1.14 0.85 1.54 5 .0222 0.65 0.45 0.94
Weight loss 4 .1098 1.38 0.93 2.04 15 .0001 1.64 1.27 2.11 48 <.0001 2.16 1.74 2.68
OR, Odds ratio; CI, confidence interval; AIDS, acquired immune deficiency syndrome; CVD, collagen vascular disease; RA, rheumatoid arthritis; NA, not available. *OR not
interpretable for spline analysis.
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Dhave set the stage for a significant debate that has often
focused on the role of surgeon experience, or
inexperience, with the performance of OPCAB and the
effect of surgeon volume on outcomes. Little has been
published regarding this issue.The Journal of Thoracic and CaThe most significant results of the present study are the
repeated demonstration of a significant surgeon volume–
outcome relationship that exists for the performance of
OPCAB in the modern surgical era and the magnitude of
this effect relative to other determinants of patient mortality.rdiovascular Surgery c Volume 143, Number 4 859
FIGURE 2. Each plot presents restricted cubic spline functions for the unadjusted relationship between surgeon volume and probability of in-hospital
death. Separate plots are presented for patients undergoing OPCAB and conventional CABG in the United States for the years 2004, 2006, and 2007.
The estimated function is presented by the solid line,with dashed lines depicting the 95% confidence intervals of the functions.OPCAB, Off-pump coronary
artery bypass; CABG, coronary artery bypass grafting.
Acquired Cardiovascular Disease LaPar et al
A
C
DThese results are in disagreement with a prior report from
aNewYork State registry that failed to demonstrate a signif-
icant relationship between surgeon experience and mortal-
ity risk.13 In the present study, the effect of surgeon
volume was rigorously assessed using advanced statistical
modeling within a large, representative, multi-state patient
population. A similar cohort of patients undergoing860 The Journal of Thoracic and Cardiovascular SurgCABG with CPB was also analyzed to validate the esti-
mated effects for OPCAB because prior surgeon volume–
outcome relationships have been well established for con-
ventional on-pump CABG. As a result, similar relationships
were observed among both OPCAB and CABG cohorts
with respect to the annual number of operations performed
and the adjusted probability of in-hospital death.ery c April 2012
TABLE 3. Change in probability of death associated with a change in
surgeon volume adjusted for all patient characteristics after
performance of off-pump and on-pump coronary artery bypass
grafting
Year
Largest possible
change in
mortality risk
Minimum
probability
of death
Maximum
probability
of death
OPCAB
2003 5.4% 1.1% 6.5%
2004 3.9% 2.4% 6.3%
2005 2.0% 3.7% 5.7%
2006 1.3% 2.9% 4.2%
2007 2.0% 3.3% 5.3%
CABG
2003 3.3% 1.9% 5.2%
2004 3.4% 1.7% 5.1%
2005 1.8% 0.8% 2.6%
2006 3.1% 0.4% 3.5%
2007 1.6% 0.6% 2.2%
OPCAB, Off-pump coronary artery bypass; CABG, coronary artery bypass grafting.
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DFurthermore, to provide a true clinical estimate of the effect
of surgeon volume on risk-adjusted mortality, the maximum
possible effect that surgeon volume could have on mortality
risk for the average patient was calculated. On the basis
of these estimates, if an ‘‘average’’ patient undergoing
OPCAB by a surgeon with the lowest possible volume
were instead operated on by a surgeon with the highest pos-
sible volume, the absolute reduction in the probability of
death could be as high as 5%. In this scenario, the probabil-
ity of death would be reduced from 6% to 1%. A similar,
yet less dramatic reduction in risk-adjusted probability of
death (3%) was estimated for those undergoing CABG
operations by high- and low-volume surgeons.
Despite these significant relationships, the relative
strength of association between surgeon volume and the
probability of death was comparatively small relative to
other patient- and operation-related risk factors. On exami-
nation of other risk factors (Table 2), the relative contribu-
tion of each covariate to the performance of a statistical
model, and thus the relative strength of association between
each covariate and the dependent outcome of interest (prob-
ability of death), should be noted by the calculated test sta-
tistic for each covariate. For the performance of OPCAB,
the relative strength of surgeon volume ranked in the lower
50th percentile of analyzed risk factors. In fact, other well-
established risk factors for cardiac surgical outcomes had
higher relative strength within the models, including preop-
erative renal failure, hypertension, metabolic disturbance,
congestive heart failure, female gender, diabetes, and the
performance of bypass with single or double ITA. The
test statistics for some of these factors were surprisingly
high (ie, hypertension), which may reflect real differences,
differences in hospital reporting of certain conditions asso-
ciated with patients at higher risk of death, or other spuriousThe Journal of Thoracic and Caassociations. Overall, however, the results indicate that al-
though surgeon volume may be a significant risk factor
for in-hospital mortality after the performance of OPCAB,
other potentially modifiable patient and operative risk fac-
tors should be more strongly considered during individual
patient risk stratification and preoperative decisions regard-
ing the performance of CABG with or without CPB.
Important to consider in the interpretation of these results
is the statistical methodology used to derive the reported es-
timated effects. Because of the complex sampling nature of
the NIS datasets, hierarchic multiple regression methods
were used to account for clustering of data at the surgeon
and hospital levels. Unlike the methodology used in prior
reports of the effect of surgeon volume on OPCAB out-
comes,13 the use of restricted cubic spline functions within
the models of the present study allowed for the adequate as-
sessment of surgeon volume as a continuous variable within
the model. Cubic spline functions are often used to assess
the shape and strength of relationships that exist between
continuous predictor variables and dependent outcomes of
interest.18,24 These functions allow for the representation
of nonlinear relationships between continuous variables
and outcomes to provide for a robust final multiple
regression model. As a result, in the present study,
a significant nonlinear relationship was demonstrated
between individual surgeon volume and probability of
death; however, no significant linear relationships were
revealed. The fact that surgeon volume was not significant
for OPCAB or CABG when analyzed as a linear function
underscores the importance of using such nonlinear
transformations of continuous data to better characterize
the nature of subtle volume–outcome relationships and to
provide more precise estimates of effects. More important,
the representation of surgeon volume as a continuous
variable within these models avoided the inherent problems
of categorizing such data for subsequent analysis. An all-
to-common practice in medical and surgical literature,
categorization of continuous data is often arbitrary and inef-
fective in adequately defining statistical relationships.19,25
With respect to an issue such as surgeon- or hospital-
related volume–outcome relationships, such practice may
lead to inappropriate conclusions that may have significant
implications on clinical practice, surgical referral patterns,
and hospital quality assessment.
Study Limitations
This study has select limitations and considerations that
deserve further discussion. The influence of selection bias
in any large, observational analysis cannot be dismissed.
Furthermore, the inherent selection bias represented at the
surgeon level for the performance of OPCAB versus
CABG must be considered in any such comparative analy-
sis. Further, the potential for unrecognized miscoding of di-
agnostic and procedure codes must be recognized in anyrdiovascular Surgery c Volume 143, Number 4 861
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Dsecondary analysis of administrative data. Despite the num-
ber of factors that seem to have a significant negative impact
on mortality, the performance of elective operations and the
use of ITA grafts would be associated with improved odds
of mortality. In addition, the use of a large administrative
database to scrutinize curious or surprising results, such
as the apparently low ITA use in this study or conversion
rates from OPCAB to CABG, is limited, as well as the abil-
ity to risk-adjust for certain cardiac surgical risk factors, in-
cluding preoperative ejection fraction, New York Heart
Association functional class, cannulation and clamping
strategies, CPB time, bypass graft harvesting technique,
and the influence of medications known to affect cardiac
surgical outcomes. Surgeon volume for OPCAB was not
statistically significant for each year analyzed, which fur-
ther suggests that the statistically significant relationship
between annual surgeon volume and probability of death af-
ter OPCAB is incrementally small compared with other
well-established risk factors that were associated with mor-
tality for all operative years. Further, because of the nature
of the NIS database and the fact that unique surgeon identi-
fiers could only be reliably tracked within a given year, it
was necessary to analyze the effect of surgeon volume
within each operative year separately as opposed to pooling
data from all operative years. Likewise, both OPCAB and
CABG cohorts were analyzed separately. Finally, the rela-
tively high percentage of OPCAB operations represented
in this dataset should be considered. This likely reflects
the exclusion of many states because of imprecise individ-
ual surgeon volume reporting. Nevertheless, in the assess-
ment of surgeon volume and its effect on risk-adjusted
mortality, the use of NIS provides great strength in its ability
to capture a large, broadly generalizable patient population
and surgeons with a great range of experience. As a result,
these analyses provide important insight into an unan-
swered question regarding the influence of annual surgeon
volume on reported outcomes for the performance of
OPCAB and CABG procedures.CONCLUSIONS
The present results demonstrate that a significant surgeon
volume–outcome relationship exists for mortality after sur-
gicalmyocardial revascularization, particularly forOPCAB,
with an apparent threshold of more than 50 operations per
year. Performance of OPCAB by the highest volume sur-
geons may result in an absolute reduction in the probability
of death of approximately 1% to 5%, which is greater than
that estimated for the performance of conventional on-pump
CABG. Despite these estimates, the contribution of surgeon
volume to the probability of death is incrementally small
compared with other patient and operative characteristics.
Thus, outcomes after OPCAB seem to reflect the greater in-
fluence of risk factors other than surgeon volume.862 The Journal of Thoracic and Cardiovascular SurgReferences
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DDiscussion
Dr R. Morton Bolman (Boston, Mass). This is a nice study ex-
amining the effect of surgeon volume on outcomes after both on-
pump CABG and OPCAB. Your findings that the median volumes
were 105 cases per surgeon were interesting and represented that
this was a relatively unusual population in that regard. There was
an incidence of 38% ofOPCAB in this population, which is approx-
imately twice the percentage across the Society of Thoracic Sur-
geons’ database in the United States. In that light, do you think
this is representative of what is going on across the United States
in terms of your outcome?
Dr LaPar (Charlottesville, Va). Those are important observa-
tions in our data. I would absolutely echo the fact that the higher
percentage or high proportion of OPCAB cases represented in
this analysis is higher than in other reported series. It may not nec-
essarily be representative of what is occurring nationwide. As I
mentioned, we did have to exclude some states that didn’t report,
and that may have skewed the data in some respect. However,
skewing that data may have helped us to detect subtle relationships
and to quantify the surgeon–outcome relationship, because it al-
lowed us to analyze a higher percentage of OPCAB cases.
Dr Bolman. As you mentioned, you found that patients under-
going operations between the surgeons with the highest and lowest
volume off-pump experience might have as much as a 5% differ-
ence in outcome, and approximately 3% for on-pump. Looking
at this with an eye to improving performance of OPCAB across
the board, would you comment on how you might use these data
going forward? What do you recommend? First, is there a volume
of OPCAB that a surgeon should be doing? You gave some general
ideas there. But if a surgeon is not performing more than 30 or 40
CABGs per year, should he/she do on-pump versus off-pump?
Dr Lapar. Those are both important points. I wasn’t necessarily
surprised to see that there was a statistically significant surgeon–
volume relationship for OPCAB. That is fairly well known. One
of the important points is that the difference in the adjusted prob-
ability of death that occurs from low- to high-volume surgeons
falls in a continuum of anywhere from 1% to 5%. The 5% value
that we noted on the top end was for 1 year, and that year was
back near the beginning of our analysis.
In terms of recommendations, I would be hesitant, on the basis of
an observational study like this, to recommend a specific threshold
for surgeons to strive for, especially in light of the fact that although
this is a statistically significant relationship, the strength of associ-
ations is lower than other factors, even, for example, hypertension.
Dr Bolman. Finally, if you look at this conversely, is there
a mechanism whereby surgeon or system performance can be
improved even for lower-volume surgeons and programs to the
level observed in the higher-volume programs, by focusing on
quality, for example, the National Quality Forum standards? I raise
this issue because of the earlier article by Kurlansky and col-
leagues, where they found no correlation between volume and out-
come for CABG across the board and found that quality issuesThe Journal of Thoracic and Cawere more important than volume. Would you care to comment
on that?
Dr Lapar. Of course, quality issues, as you mentioned, are dif-
ficult to assess in a study like this, but we would recommend cen-
ters that are proven centers of excellence in this respect, regardless
of their volume.
Dr Bolman. This type of comparative effectiveness research is
extremely important as we look at the adoption of new techniques.
DrRichardShemin (Los Angeles,Calif). Very nice study.Do you
have any data to suggest that low-volume OPCAB surgeons perform
operations in higher-risk patients and that thehigher-volume surgeons
have a better distribution of the other risk factors in their cohorts?
Dr Lapar. No, we don’t have those data, and we didn’t analyze
the data that we do have with respect to that. That is an important
observation, though. I would suspect that higher-volume surgeons
have a wider distribution in the patients they see, and it may even
be that low-volume surgeons, although patients may be at high or
low risk, are a factor.
DrGregory Hirsch (Halifax, NS, Canada). Congratulations on
an excellent study. From time to time, we have used administrative
data in Canada for a Pan-Canadian look at various problems using
Canadian Institutes ofHealth information data, andwe have always
been concerned about data quality and accuracywhenever possible,
and in 1 to 3 provinces, we can invariably seek to validate the data-
set we have with detailed observational data. Did you have any op-
portunity to do thatwhen there is a statewide initiative, and there are
several in the United States, to match up your observational data?
Dr Lapar. You point out an important limitation in secondary
analyses of administrative databases. Currently we haven’t had
a chance to validate these results in any sort of a surgical database
or a more specific quality initiative database. We do have a state
quality initiative database that provides Society of Thoracic Sur-
geons’ data within the Commonwealth of Virginia. However, our
decision to use this particular administrative database is surely
to obtain a reasonable sample size fromwhich to analyze this ques-
tion. The database that we have access to currently just didn’t have
sufficient numbers to do that. I do think this should be validated in
a larger nationwide surgical database, such as the Society of Tho-
racic Surgeons’ adult cardiac database, if possible.
DrValavanur Subramanian (New York, NY). Several years ago
at this society’s annual meeting, we presented the incremental risk
of emergencyOPCABconversion onmortality andmorbidity in our
own large database. Is there any way to identify the conversion in
this national database sample? A low-volume surgeon perhaps
may have a higher emergency conversion contributing to higher
mortality correlation to surgical volume. A reduction in conversion
rate inOPCABby routine use of intracoronary shunt and cardiac po-
sitioning device may be helpful. This is an earlier study, and most
people would use a positioning device. Do you have any comment?
Dr Lapar.Within this database, it would be possible to come up
with a scheme to identify within the same hospitalization whether
or not a patient had 1 or both operations. As we discussed earlier in
the afternoon in a similar study, there are some procedure variables
within the NIS dataset that allow you to identify the day that oper-
ations are performed. But I think using those in a setting like this
makes some broad assumptions that I don’t know if I feel comfort-
able doing. I think those questions are better addressed with more
specific surgical databases.rdiovascular Surgery c Volume 143, Number 4 863
